techMARK (TASX)

5,647.78
   
  • Change Today:
      36.59
  • 52 Week High: 5,661.11
  • 52 Week Low: 4,135.10

Latest ShareCast News

GSK's COPD treatment approved by Chinese regulators

By Benjamin Chiou

Date: Monday 05 Jan 2026

(Sharecast News) - Pharma giant GSK has received regulatory approval in China for its Nucala treatment for adults with inadequately controlled chronic obstructive pulmonary disease (COPD).

techMARK Regulatory News

Form 8.3 NCC GROUP PLC 05-Jan-2026 12:29 RNS
Total Voting Rights 05-Jan-2026 12:28 RNS
Form 8.3 - NCC Group plc 05-Jan-2026 12:03 RNS
Form 8.5 (EPT/RI) NCC Group PLC 05-Jan-2026 12:00 RNS
Form 8.3 NCC Group Plc 05-Jan-2026 11:11 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Price Data

Price 5,647.78
Change Today 36.59
% Change 0.65 %
02-Jan-26 Close 5,611.19

Top Risers

Price Change
BA. 1,841.50p +5.0%
XPP 918.00p +2.7%
QQ. 455.60p +2.5%
CCC 2,978.00p +2.0%
OXB 664.00p +1.4%
VOD 100.20p +1.0%
FLTR 16,220.00p +0.6%
GNS 2,555.00p +0.4%
OXIG 2,060.00p +0.2%
XAR 102.00p +0.0%

Top Fallers

Price Change
TRD 255.00p -1.9%
BT.A 180.30p -1.9%
NCC 133.20p -0.9%
DIA 344.00p -0.9%
SGE 1,044.50p -0.5%
RSW 3,540.00p -0.3%
GSK 1,828.50p -0.2%
SN. 1,217.00p -0.0%
APTD 294.00p -0.0%

Top of Page